Amanda Tchakarov

The University of Texas Health Science Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Checkpoint inhibitor-related renal vasculitis and use of rituximab”.

Checkpoint inhibitor-related renal vasculitis and use of rituximab

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000750

N/A

0DataRank · unranked

47 citations

Jamie S. Lin, Maen Abdelrahim, Amanda Tchakarov, William F. Glass, Umut Selamet +4 more

Tertiary lymphoid structure signatures are associated with immune checkpoint inhibitor related acute interstitial nephritis

JCI Insight(2022)10.1172/jci.insight.165108

N/A

0DataRank · unranked

39 citations

James P. Long, Amanda Tchakarov, Yanlan Dong, Cassian Yee, Jamie S. Lin +1 more

Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma

Frontiers in Immunology(2022)10.3389/fimmu.2022.898811

N/A

0DataRank · unranked

15 citations

Vikas D. Reddy, Jaya Kala, Amanda Tchakarov, William F. Glass, Pavlos Msaouel +2 more

Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab

Frontiers in Nephrology(2023)10.3389/fneph.2023.1168614

N/A

0DataRank · unranked

5 citations

Naszrin Arani, Vishnu P. Parvathareddy, Amanda Tchakarov, Maen Abdelrahim, María E. Suarez‐Almazor +6 more

Rituximab for the treatment of immune checkpoint inhibitor–induced glomerulonephritis

Clinical Kidney Journal(2025)10.1093/ckj/sfaf373

N/A

0DataRank · unranked

1 citations

Javier Blanco García, Naszrin Arani, Valda D. Page, Yimin Geng, Clark R. Andersen +5 more

Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence

Kidney International Reports(2025)10.1016/j.ekir.2025.10.018

N/A

0DataRank · unranked

0 citations

Masroor Habeeb, Hong Chen, Zainab Alhamal, Omar Mamlouk, Heather Lin +7 more